Study Finds Long Term Night Shift Work Breast Cancer Risk

Study finds long term night shift work associated with increased breast cancer risk

Friday, July 5, 2013. The results of a Canadian study published online on July 1, 2013 in the journal Occupational and Environmental Medicine reveal a significant association between long term night shift work and a higher risk of breast cancer. Although earlier research had uncovered a similar link among nurses, the current study demonstrates the association among members of the general population.

"While the biological mechanism linking night shift work with cancer risk remains unknown, the main hypothesised pathway involves melatonin," write Anne Grundy of Queen's University in Ontario and her coauthors in their introduction to the article. "Melatonin, a pineal hormone that is inhibited by light and considered a biomarker of chronodisruption, has also been suggested to have several cancer-protective properties. While increased light exposure during night shifts is thought to decrease production of melatonin, thereby increasing cancer risk, other mechanisms are also possible."

The researchers compared 1,134 women with breast cancer to 1,179 age-matched women who did not have the disease. Questionnaires completed by the participants provided information concerning years spent working night shifts.

Approximately one-third of women in both groups reported a history of night shift work. While no association was found for women who worked night shifts from zero to 14 years or 15 to 29 years, those who worked night shifts for at least thirty years had more than twice the risk of breast cancer than subjects who reported no night shift work. The risk of breast cancer among these very long term night shift workers was greater for those with estrogen/progesterone receptor-positive cancers than for those with estrogen/progesterone receptor negative cancers; however, the small number of women in these groups prevented the researchers from confirming a significant effect.

While a reduction in melatonin resulting from nighttime light exposure among night shift workers is one mechanism proposed for their greater risk of breast cancer risk, the authors remark that other mechanisms, including sleep disturbances, clock gene dysregulation and lifestyle differences, could also play a role. It has also been suggested that a decrease in vitamin D production due to reduced sunlight exposure experienced by night shift workers could contribute to increased disease risk.

"As shift work is necessary for many occupations, understanding which specific shift patterns increase breast cancer risk, and how night shift work influences the pathway to breast cancer, is needed for the development of healthy workplace policy," the authors conclude.

What's Hot

Cherry juice improves sleep

What's Hot

An article published on November 8, 2011 in the European Journal of Nutrition reveals the results of a randomized, crossover trial which found that cherry juice drinkers slept longer and better than those who didn't consume the juice.

Glyn Howatson and colleagues from Northumbria University compared the effects of Montmorency tart cherry juice or a placebo drink in 20 men and women aged 18 to 40 years. Participants were instructed to consume one serving upon awakening and another before bed for seven days. The subjects subsequently switched regimens following a two-week period in which no drinks were administered. Daily diaries recorded information on the participants' sleep quality, which was corroborated with a wearable sleep monitor. Urine samples obtained before and during the trial were analyzed for 6-sulphatoxymelatonin, the major metabolite of melatonin: a sleep-promoting hormone that occurs in cherries.

Participants who received tart cherry juice had significant elevations in urinary melatonin content, while the placebo group's levels remained the same as those measured at the beginning of the trial. Drinking cherry juice was associated with an average of 39 minutes longer sleep, more time in bed spent asleep, better sleep quality and less daytime napping compared to the placebo group. While increased melatonin is the primary mechanism to which the improved sleep of those who consumed cherry juice was attributed, the authors note that sleep regulation is also influenced by pro-inflammatory cytokines and that tart cherries have numerous phenolic compounds that have anti-inflammatory properties.

"This is the first study to show direct evidence that dietary supplementation with a tart Montmorency cherry juice concentrate increases circulating melatonin and can provide modest improvements in sleep time and quality in healthy adults with no reported disturbed sleep," they announce. "Tart cherry juice concentrate might therefore present a suitable adjunct intervention for disturbed sleep across a number of scenarios in healthy and symptomatic individuals."

Latest Supplements 

Enhanced FernBlock® with Red Orange Complex, 30 vegetarian capsules
Item #01728

add to cart

FernBlock® has shown remarkable effectiveness in promoting skin defenses against harmful solar radiation. FernBlock® works by promoting the body's ability to inhibit absorption of ultraviolet rays and to quench the free radicals that this type of radiation can generate.

This product has been upgraded to contain Red Orange Complex, a standardized extract that is obtained from three red orange varieties—Citrus sinensis var. Moro, Tarocco, and Sanguinello. The main active phenolic compounds include anthocyanins, flavanones, and hydroxycinnamic acids. In a controlled human trial, fifteen days of oral supplementation with Red Orange Complex was demonstrated to measurably support natural skin defenses against ultraviolet radiation.

FernBlock® is a registered trademark of Industrial Farmaceutica Cantabria, S.A.

Kyolic® Garlic Formula 102

Brite Eyes III
2 vials, 5 ml each

Item #00893

add to cart

As we get older, our eyes become vulnerable to a variety of insults that can cause irritation and dry eye. Applying lubricating eye drops several times a day can alleviate discomfort. The Brite Eyes III formula contains two proven lubricants (hydroxypropylmethylcellulose and glycerin) that are FDA-approved for ophthalmic use without irritation. The Brite Eyes III formula also contains the antioxidant N-acetyl-carnosine, which helps protect the active ingredients against glycation.

A box of Brite Eyes III contains two individual vials that hold five milliliters each. This type of packaging in two individual vials reduces the risk of bacterial contamination. And having two vials also makes it convenient for consumers to keep Brite Eyes III readily accessible at home, in the office, purse or pocket … or anywhere access to soothing eye drops is needed.



Life Extension Update What's Hot
Study sheds light on how exercise reduces breast cancer risk Melatonin linked with cancer protection
More sleep reduces breast cancer risk Breast cancer risk associated with less sleep in large study population
Higher urinary melatonin level associated with lower risk of breast cancer Analysis finds inverse relationship between serum vitamin D levels and breast cancer risk
Life Extension Magazine® Health Topics
Melatonin: new research shows impressive health benefits Breast cancer
Melatonin and cancer treatment Insomnia
Melatonin to prevent breast cancer! Complementary alternative cancer therapies